Cochlear (CHEOF) News Today $202.69 0.00 (0.00%) As of 08/7/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock CHEOF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Morgan Stanley Sticks to Its Sell Rating for Cochlear (CHEOF)August 7 at 6:21 AM | theglobeandmail.comHealth Check: Audeara strives to be ‘the next Cochlear’ in affordable hearing collabAugust 6 at 3:28 AM | msn.comAussies missing out on payoff from research investmentJuly 28, 2025 | msn.comCochlear Limited to Announce FY25 Financial ResultsJuly 27, 2025 | tipranks.comCochlear Gains FDA Approval for New Hearing SolutionsJuly 7, 2025 | tipranks.comCochlear takes fast lane as it brings new hearing device to Chinese marketJuly 4, 2025 | msn.comUK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing LossJuly 1, 2025 | tmcnet.comTech boss fears AI regulations will hamper innovationJune 24, 2025 | au.news.yahoo.comCochlear (CHEOF) Receives a Hold from JardenJune 18, 2025 | theglobeandmail.comiotaMotion Announces Issuance of U.S. Patent for Robotic-Assisted Cochlear Implantation TechnologyJune 11, 2025 | finance.yahoo.comLabor takes $27m stake in breakthrough eye biotechMay 29, 2025 | afr.comBed Shaker fire alarms improve fire safety for people who are deafMay 21, 2025 | msn.comUP CM calls for compassionate governance in Divyang schoolsMay 21, 2025 | msn.comUP CM Yogi Adityanath Orders Audit Of Divyang Institutions, Emphasizes Student Safety & DignityMay 21, 2025 | msn.comCochlear-backed Epiminder targets 2025 IPO as FDA authorisation landsApril 22, 2025 | afr.com‘Could be next Cochlear or ResMed’: heart device maker wins FDA approvalApril 14, 2025 | afr.comJEFFERIES Upgrades Cochlear (CHEOF)April 8, 2025 | msn.comCochlear Ltd. (CHEOF) ChartsApril 8, 2025 | nasdaq.comAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)July 26, 2023 | markets.businessinsider.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 19, 2023 | msn.comSensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 19, 2023 | benzinga.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsJuly 18, 2023 | msn.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)July 10, 2023 | markets.businessinsider.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 10, 2023 | benzinga.comSensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical StudyJuly 5, 2023 | benzinga.comRajasthan: Govt announces ₹1 lakh airfare for travel for organ transplantJune 25, 2023 | msn.comNHS may have missed thousands of deaf children in ‘huge national failure’June 25, 2023 | thetimes.co.ukTFTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid SpeculationJune 22, 2023 | morningstar.comMLabor bows to pressure on multinational tax disclosureJune 22, 2023 | afr.comSensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical StudyJune 19, 2023 | finance.yahoo.com‘Next Cochlear’ stock surges after heart device breakthroughMay 21, 2023 | afr.comCochlear Implants Market Share | Business till 2030May 4, 2023 | marketwatch.comParents to inform SA cochlear implant reviewMay 3, 2023 | msn.comTownsville University Hospital staff stood down amid review of paediatric audiology unit outcomesApril 20, 2023 | msn.comAustralian business delegation heads to ChinaApril 16, 2023 | afr.comSurgeries of chronically ill children in Pune pending under RBSKApril 11, 2023 | msn.comCochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the MarketApril 6, 2023 | marketwatch.comSensorion Announces Candidate Selection for GJB2 Gene Therapy ProgramApril 6, 2023 | marketwatch.comDad runs half marathon to help deaf babies like his sonMarch 22, 2023 | uk.news.yahoo.comCochlear, Demant contest UK regulator's Oticon deal concernsMarch 22, 2023 | nasdaq.comDr. Jace Wolfe named Senior Vice President at Oberkotter Foundation - Hearing FirstMarch 21, 2023 | markets.businessinsider.comThis company found the miracle cancer cure – then dropped itMarch 13, 2023 | afr.com‘The worst is yet to come’: big business gears up for Canberra fightMarch 7, 2023 | afr.comGlobal Cochlear Implant (CI) System Market 2023 (Latest Report) is booming in near Future 2028February 22, 2023 | marketwatch.comCochlear Implant (CI) System Market Size, Share and Forecast 2028 with Top Countries DataFebruary 20, 2023 | marketwatch.comMeet the profoundly deaf boy who is celebrating being able to speak and hearFebruary 20, 2023 | uk.news.yahoo.comCochlear Limited (CHEOF) Q2 2023 Earnings Call TranscriptFebruary 17, 2023 | seekingalpha.comCochlear GAAP EPS of $2.15, revenue of $893M beats by $292.36MFebruary 16, 2023 | msn.comUBS says buy Lynas Corp; Citi lifts CSL valuation, CBA sinksFebruary 15, 2023 | afr.com Get Cochlear News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEOF and its competitors with MarketBeat's FREE daily newsletter. Email Address CHEOF Media Mentions By Week CHEOF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CHEOF News Sentiment▼-0.290.38▲Average Medical News Sentiment CHEOF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CHEOF Articles This Week▼21▲CHEOF Articles Average Week Get Cochlear News Delivered to You Automatically Sign up to receive the latest news and ratings for CHEOF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ainos News Bone Biologics News Evome Medical Technologies News GN Store Nord A/S News Heart Test Laboratories News Imagin Medical News Inspira Technologies Oxy B.H.N. News Ion Beam Applications News Medacta Group News Nova Eye Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CHEOF) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CHEOF Stock Alerts